The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors in newly diagnosed glioblastoma: Have we missed gender?
E. Franceschi
No relevant relationships to disclose
A. Tosoni
Consultant or Advisory Role - Merck Sharp & Dohme
S. Bartolini
No relevant relationships to disclose
L. Scopece
No relevant relationships to disclose
L. Lombardo
No relevant relationships to disclose
R. Poggi
No relevant relationships to disclose
V. Mazzocchi
No relevant relationships to disclose
L. La Torre
No relevant relationships to disclose
M. Ermani
No relevant relationships to disclose
A. A. Brandes
Consultant or Advisory Role - Roche; Schering-Plough
Honoraria - GlaxoSmithKline; Schering-Plough